Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2025-12-16 @ 8:56 PM
Study NCT ID:
NCT06154902
Status:
None
Last Update Posted:
2023-12-04 00:00:00
First Post:
2023-11-27 00:00:00
Brief Title:
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
CA089-1041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None